Caricamento...
Inflammatory Cytokine Profile in Crohn’s Disease Non-Responders to Optimal Anti-Tumor Necrosis Factor Therapy
BACKGROUND: A significant number of patients receiving therapy with anti-tumor necrosis factor (TNF) agents for Crohn’s disease (CD) experience primary or secondary non-response. The aim of this study was to assess if patients with non-response to anti-TNF agents have increased expression of alterna...
Salvato in:
| Pubblicato in: | J Clin Gastroenterol |
|---|---|
| Autori principali: | , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6127004/ https://ncbi.nlm.nih.gov/pubmed/29517712 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MCG.0000000000001002 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|